story of the week
Breakthrough SARS-CoV-2 Infections After COVID-19 mRNA Vaccination in Patients With MS on Disease-Modifying Therapies During the Delta and Omicron Waves in Italy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
eBioMedicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
EBioMedicine 2022 May 05;80(2022)104042, MP Sormani, I Schiavetti, M Inglese, L Carmisciano, A Laroni, C Lapucci, V Visconti, C Serrati, I Gandoglia, T Tassinari, G Perego, G Brichetto, P Gazzola, A Mannironi, ML Stromillo, C Cordioli, D Landi, M Clerico, E Signoriello, E Cocco, J Frau, MT Ferrò, A Di Sapio, L Pasquali, M Ulivelli, F Marinelli, M Pizzorno, G Callari, R Iodice, G Liberatore, F Caleri, AM Repice, S Cordera, MA Battaglia, M Salvetti, D Franciotta, A UccelliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.